[
  {
    "ts": null,
    "headline": "What Bristol-Myers Squibb (BMY)'s Triple-Negative Breast Cancer Phase III Survival Win Means For Shareholders",
    "summary": "In late February 2026, Bristol Myers Squibb and partner SystImmune reported that antibody-drug conjugate izalontamab brengitecan (iza-bren) achieved statistically significant, clinically meaningful improvements in both progression-free and overall survival versus chemotherapy in a Phase III trial for previously treated unresectable locally advanced or metastatic triple-negative breast cancer. This marks the third successful pivotal study for iza-bren and the first bispecific antibody-drug...",
    "url": "https://finnhub.io/api/news?id=52598649dd62b44189136ef92101a5e3286f34b06a771b64001cf9ecc83b4de4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772374278,
      "headline": "What Bristol-Myers Squibb (BMY)'s Triple-Negative Breast Cancer Phase III Survival Win Means For Shareholders",
      "id": 139270606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "In late February 2026, Bristol Myers Squibb and partner SystImmune reported that antibody-drug conjugate izalontamab brengitecan (iza-bren) achieved statistically significant, clinically meaningful improvements in both progression-free and overall survival versus chemotherapy in a Phase III trial for previously treated unresectable locally advanced or metastatic triple-negative breast cancer. This marks the third successful pivotal study for iza-bren and the first bispecific antibody-drug...",
      "url": "https://finnhub.io/api/news?id=52598649dd62b44189136ef92101a5e3286f34b06a771b64001cf9ecc83b4de4"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement",
    "summary": "Bristol Myers Squibb has an attractive 4% yield and a strong dividend history.",
    "url": "https://finnhub.io/api/news?id=0a7ae91fefc7dbc52b81e237cc9424890f5e04fc726b2e604d2b54dee15f63f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772340600,
      "headline": "Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement",
      "id": 139268007,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers Squibb has an attractive 4% yield and a strong dividend history.",
      "url": "https://finnhub.io/api/news?id=0a7ae91fefc7dbc52b81e237cc9424890f5e04fc726b2e604d2b54dee15f63f0"
    }
  }
]